FDA Approved: JADENU — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for JADENU (deferasirox) from Novartis Pharmaceuticals Corporation, expanding its labeling for iron chelation in transfu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major
• Myelodysplastic Syndrome
• Sickle Cell Disease

Drugs mentioned

• JADENU (deferasirox)

Snippet

SUPPL AP for JADENU (DEFERASIROX)